Actinium Pharmaceuticals (ATNM) Q3 2024 Earnings

5AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-0.51
-0.34
-0.17
0

Details

Expected EPS
-0.405
Actual EPS
-0.34
Surprise EPS
0.07
Surprise Percent
+16.05%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.34 per share for Q3 2024.

0 Comments

Share your thoughts